Modifies provisions relating to epinephrine delivery devices
HB 2349 modifies Missouri's epinephrine auto-injector regulations, likely expanding access or liability protections for life-saving emergency allergy response devices.
HB 2349 modifies Missouri's epinephrine auto-injector regulations, likely expanding access or liability protections for life-saving emergency allergy response devices.
HB 2349 modifies Missouri's regulations governing epinephrine auto-injector devices (EpiPens). Based on the bill's title and legislative progression, it likely addresses accessibility, storage, administration protocols, or liability protections related to epinephrine delivery in schools, public spaces, or emergency settings. The specific modifications are not detailed in the available action items.
Epinephrine auto-injectors are life-saving devices for individuals experiencing severe allergic reactions (anaphylaxis). Regulatory changes can significantly impact availability in schools and public spaces, response times during medical emergencies, and the willingness of institutions to stock these devices. Clearer policies reduce legal barriers that sometimes prevent bystanders or untrained individuals from administering epinephrine when seconds matter.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.